JamesFWatkinsIIIMD

Oncology • Pensacola, FL

Physician

Join to view full profile

Are you Dr. Watkins?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 59 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1545 Airport Blvd
Suite 2000
Pensacola, FL 32504
Phone+1 850-416-6933

Fax+1 850-416-6934
Is this information wrong?

Summary

Dr. James Watkins III, MD is an oncologist in Pensacola, Florida. He is currently licensed to practice medicine in Florida, Alabama, and Kansas. He is affiliated with Ascension Sacred Heart Pensacola.

Education & Training

University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
Ochsner Clinic FoundationResidency, Internal Medicine, 2003 - 2006
University of Kansas School of MedicineClass of 2003

Certifications & Licensure

MO State Medical License 2006 - 2025
FL State Medical License 2009 - 2025
KS State Medical License 2006 - 2024
AL State Medical License 2009 - 2024
LA State Medical License 2004 - 2024
American Board of Internal Medicine Medical Oncology

Clinical Trials

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Completed
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Anatomic site of tube feeding influences glycemic control—an evidence-based hypothesis
Taufiek Konrad Rajab, James F. Watkins> ;Surgery. 2013 May 1
10 citations
Experience with corrective surgery for postburn contractures in Mumbai, India.
Francis Sun Kim, Huong H. Tran, Indranil Sinha, Anup Patel, Rebecca A. Nelson, Ankur Pandya, Sunil Keswani, James F. Watkins> ;Journal of Burn Care & Research. 2012 May 1
16 citations
CABG after successful PTCA: A case-control study
Robert G. Johnson, Cheryl Sirois, James F. Watkins, Robert L. Thurer, Frank W. Sellke, William E. Cohn, Richard E. Kuntz, Ronald M. Weintraub> ;The Annals of Thoracic Surgery. 1995 Jun 1

Hospital Affiliations

Ascension Sacred Heart PensacolaPensacola, Florida